TheJakartaPost

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post

Indonesia puts convalescent plasma on pedestal. But how effective is it?

  • Ardila Syakriah
    Ardila Syakriah

    The Jakarta Post

PREMIUM
Jakarta   /   Tue, January 26, 2021   /  12:53 pm
The Jakarta Post Image
A nurse treats a COVID-19 patient at Bogor General Hospital in Bogor, West Java, on Sept. 3, 2020.(AFP/Adek Berry)

The government recently kicked off a national campaign to encourage COVID-19 survivors to donate their convalescent plasma for patients, as clinical trials are ongoing in Indonesia, despite other countries having halted their trials following undesired results. Coordinating Human Development and Culture Minister Muhadjir Effendy cited a preliminary study by Saiful Anwar Regional General Hospital (RSUD) in Malang, East Java, which found patients with severe cases who received the experimental treatment had a 100 percent rate of recovery and critical patients had an 85 percent rate of recovery. Without disclosing further details on the study, Muhadjir said "the preliminary study can be used to predict the use of convalescent plasma for COVID-19 recovery as very meaningful". But clinical trials abroad, as well as experts at home -- both involved and not involved in local ...